Equity Capital Markets

Company · CIK 1685071

Dova Pharmaceuticals Inc.

CIK1685071 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressNC
Listedno ticker on SEC record today
First annual or quarterly report2017-08-14

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-226403
ShelfEffective
 2018-07-272019-11-185
333-223103
Registered companyFinal prospectus
 2018-02-202018-02-233
333-218479
IPOFinal prospectus
 2017-06-022017-06-305

Filings

15
FiledFilingRegistrationAccession
2019-11-18EFFECTDeclared effective 333-2264039999999995-19-002592
2018-08-09424B5Shelf takedown 333-2264030001047469-18-005540
2018-08-09424B5Shelf takedown 333-2264030001047469-18-005539
2018-08-08EFFECTDeclared effective 333-2264039999999995-18-002048
2018-07-27S-3Shelf registered 333-2264030001047469-18-005260
2018-02-23424B4Final prospectus 333-2231030001047469-18-001024
2018-02-22EFFECTDeclared effective 333-2231039999999995-18-000483
2018-02-20S-1Registration filed 333-2231030001047469-18-000895
2018-01-26DRSDraft made public 377-019020000912057-18-000044
2017-06-30424B4Final prospectus 333-2184790001047469-17-004345
2017-06-28EFFECTDeclared effective 333-2184799999999995-17-001683
2017-06-19S-1/AAmendment 333-2184790001047469-17-004084
2017-06-09S-1/AAmendment 333-2184790001047469-17-003915
2017-06-02S-1Registration filed 333-2184790001047469-17-003801
2017-04-21DRSDraft made public 377-015500000912057-17-000104

All filings of this company · CSV